Australia markets close in 2 hours 57 minutes

INmune Bio, Inc. (INMB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.80+0.37 (+4.39%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2232
Avg. Estimate-0.54-0.6-2.19-1.95
Low estimate-0.57-0.63-2.45-2.09
High estimate-0.52-0.58-1.7-1.82
Year ago EPS-0.36-0.36-1.67-2.19
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate30k30k110k120k
Low estimate30k30k110k120k
High estimate30k30k110k120k
Year ago salesN/A46k155k110k
Sales growth (year/est)N/A-34.80%-29.00%9.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.02-0.4-0.39-0.44
Actual EPS-0.36-0.36-0.48-0.47
Difference-0.340.04-0.09-0.03
Surprise %-1,700.00%10.00%-23.10%-6.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.54-0.6-2.19-1.95
7 days ago-0.54-0.6-2.19-1.95
30 days ago-0.58-0.65-2.65-2.4
60 days ago-0.58-0.65-2.65-2.4
90 days ago-0.58-0.65-2.65-2.4
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1121
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesINMBIndustrySector(s)S&P 500
Current qtr.-50.00%N/AN/AN/A
Next qtr.-66.70%N/AN/AN/A
Current year-31.10%N/AN/AN/A
Next year11.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A